During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...

January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

That includes the recent decision to reject NHS use of AZ and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) for HER2-low ...

The government has allocated Rs 99,858.56 crore for the healthcare sector in the 2025-2026 Budget, marking an 11% increase ...

Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to ...

Union Finance Minister Nirmala Sitharaman in her speech said that the budget primarily focused on the 'Garib (poor), Youth, ...

Finance Minister Nirmala Sitharaman on Saturday proposed to fully exempt customs duty on 36 drugs used in the treatment of ...

Finance Minister Nirmala Sitharaman proposes full customs duty exemption on 36 life-saving drugs for cancer and rare diseases ...

The Union health ministry has been allocated Rs 99,858.56 crore in the Budget 2025-2026, an around 11 per cent hike over the ...

Finance Minister Nirmala Sitharaman announced an exemption of customs duty on 36 life-saving drugs, including those for ...